CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway

Ju,Qianqian; Jiang,Maorong; Huang,Wenxin; Yang,Qingbo; Luo,Zhenghong; Shi,Hui

doi:10.3892/or.2021.8240

CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway

Authors:
- Qianqian Ju
- Maorong Jiang
- Wenxin Huang
- Qingbo Yang
- Zhenghong Luo
- Hui Shi
View Affiliations

Affiliations: School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu 211166, P.R. China, Key Laboratory for Neuroregeneration, Medical College of Nantong University, Nantong, Jiangsu 226001, P.R. China, Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, P.R. China, Department of Thoracic Surgery, Shanghai Tenth People's Hospital, Shanghai 200072, P.R. China
Published online on: December 8, 2021 https://doi.org/10.3892/or.2021.8240
Article Number: 29
Copyright: © Ju et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

C‑terminal‑binding protein 2 (CtBP2), a transcriptional co‑repressor, plays a main role in tumorigenesis and in the development of multiple tumors. Transforming growth interacting factor (TGIF) is involved in a number of cellular signal transduction pathways and is related to tumor occurrence and development. In the present study, the proteins interacting with CtBP2 were identified and the mechanisms underlying the biological activity of CtBP2 in esophageal squamous cell carcinoma (ESCC) were investigated. The Search Tool for the Retrieval of Interacting Genes (STRING) database was used to search for known proteins interacting with CtBP2, and co‑immunoprecipitation (Co‑IP) assay was performed to validate the interactions. Reverse transcription‑quantitative PCR (RT‑qPCR), immunohistochemistry (IHC) and western blot analysis were performed to examine the expression levels of CtBP2 and TGIF in ESCC. The correlation between CtBP2 and TGIF was analyzed using Gene Expression Profiling Interactive Analysis (GEPIA) by Pearson's correlation analysis, and the co‑localization of CtBP2 with TGIF in the ECA109 cells was identified using immunofluorescence staining. XAV939 treatment, CCK‑8, 5‑ethynyl‑2'‑deoxyuridine (EdU) staining, wound healing and Transwell assays were performed to investigate the signaling pathways involved in the biological activity of CtBP2 in ECA109 cells. According to the results obtained from STRING and Co‑IP analysis, an interaction between CtBP2 and TGIF was indicated, and these proteins were co‑localized in the nucleus. CtBP2 and TGIF mRNA and protein expression levels were robustly and simultaneously increased in both ESCC tissues and cell lines. There was a direct correlation between CtBP2 and TGIF expression levels in ESCC tissues, and both were significantly associated with metastasis and survival. The TGIF and CtBP2 expression levels were significantly increased or decreased simultaneously, in ECA109 cells transfected with LV‑CtBP2 or sh‑CtBP2, and vice versa. According to the results of CCK‑8 assay, EdU staining and Transwell assay, CtBP2 promoted the proliferation, migration and invasion of ECA109 cells through the Wnt/β‑catenin pathway. On the whole, the present study demonstrates that CtBP2 interacts with TGIF and promotes the malignant progression of ESCC through the Wnt/β‑catenin pathway.

View Figures

View References

1	Lin Y, Totsuka Y, Shan B, Wang C, Wei W, Qiao Y, Kikuchi S, Inoue M, Tanaka H and He Y: Esophageal cancer in high-risk areas of China: Research progress and challenges. Ann Epidemiol. 27:215–221. 2017. View Article : Google Scholar : PubMed/NCBI
2	Yu C, Tang H, Guo Y, Bian Z, Yang L, Chen Y, Tang A, Zhou X, Yang X, Chen J, et al China Kadoorie Biobank Collaborative Group, : Hot tea consumption and its interactions with alcohol and tobacco use on the risk for esophageal cancer: a population-based cohort study. Ann Intern Med. 168:489–497. 2018. View Article : Google Scholar : PubMed/NCBI
3	Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, Wei W, Inoue M and Tanaka H: Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 23:233–242. 2013. View Article : Google Scholar : PubMed/NCBI
4	Yang S, Lin S, Li N, Deng Y, Wang M, Xiang D, Xiang G, Wang S, Ye X, Zheng Y, et al: Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: An up-to-date overview and comparison with those in Japan and South Korea. J Hematol Oncol. 13:1462020. View Article : Google Scholar : PubMed/NCBI
5	Anandavadivelan P and Lagergren P: Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 13:185–198. 2016. View Article : Google Scholar : PubMed/NCBI
6	Gao QY and Fang JY: Early esophageal cancer screening in China. Best Pract Res Clin Gastroenterol. 29:885–893. 2015. View Article : Google Scholar : PubMed/NCBI
7	Chen W, Li H, Zheng R, Ren J, Shi J, Cao M, Sun D, Sun X, Cao X, Zhou J, et al: An initial screening strategy based on epidemiologic information in esophageal cancer screening: A prospective evaluation in a community-based cancer screening cohort in rural China. Gastrointest Endosc. 93:110–118.e2. 2021. View Article : Google Scholar : PubMed/NCBI
8	Chen W, Li H, Ren J, Zheng R, Shi J, Li J, Cao M, Sun D, He S, Sun X, et al: Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China. Int J Cancer. 148:329–339. 2021. View Article : Google Scholar : PubMed/NCBI
9	Liu M, He Z, Guo C, Xu R, Li F, Ning T, Pan Y, Li Y, Ding H, Zheng L, et al: Effectiveness of intensive endoscopic screening for esophageal cancer in China: a community-based study. Am J Epidemiol. 188:776–784. 2019. View Article : Google Scholar : PubMed/NCBI
10	Kelly RJ: Emerging multimodality approaches to treat localized esophageal cancer. J Natl Compr Canc Netw. 17:1009–1014. 2019. View Article : Google Scholar : PubMed/NCBI
11	Borggreve AS, Kingma BF, Domrachev SA, Koshkin MA, Ruurda JP, van Hillegersberg R, Takeda FR and Goense L: Surgical treatment of esophageal cancer in the era of multimodality management. Ann N Y Acad Sci. 1434:192–209. 2018. View Article : Google Scholar : PubMed/NCBI
12	Chen L, Wang L, Qin J and Wei DS: CtBP2 interacts with ZBTB18 to promote malignancy of glioblastoma. Life Sci. 262:1184772020. View Article : Google Scholar : PubMed/NCBI
13	Wang H, Xiao Z, Zheng J, Wu J, Hu XL, Yang X and Shen Q: ZEB1 represses neural differentiation and cooperates with CTBP2 to dynamically regulate cell migration during neocortex development. Cell Rep. 27:2335–2353.e6. 2019. View Article : Google Scholar : PubMed/NCBI
14	Zhao LJ, Subramanian T, Vijayalingam S and Chinnadurai G: PLDLS-dependent interaction of E1A with CtBP: Regulation of CtBP nuclear localization and transcriptional functions. Oncogene. 26:7544–7551. 2007. View Article : Google Scholar : PubMed/NCBI
15	Jecrois AM, Dcona MM, Deng X, Bandyopadhyay D, Grossman SR, Schiffer CA and Royer WE Jr: Cryo-EM structure of CtBP2 confirms tetrameric architecture. Structure. 29:310–319.e5. 2021. View Article : Google Scholar : PubMed/NCBI
16	Ma Y, Sekiya M, Kainoh K, Matsuda T, Iwasaki H, Osaki Y, Sugano Y, Suzuki H, Takeuchi Y, Miyamoto T, et al: Transcriptional co-repressor CtBP2 orchestrates epithelial-mesenchymal transition through a novel transcriptional holocomplex with OCT1. Biochem Biophys Res Commun. 523:354–360. 2020. View Article : Google Scholar : PubMed/NCBI
17	Wang DP, Gu LL, Xue Q, Chen H and Mao GX: CtBP2 promotes proliferation and reduces drug sensitivity in non-small cell lung cancer via the Wnt/β-catenin pathway. Neoplasma. 65:888–897. 2018. View Article : Google Scholar : PubMed/NCBI
18	Thio SS, Bonventre JV and Hsu SI: The CtBP2 co-repressor is regulated by NADH-dependent dimerization and possesses a novel N-terminal repression domain. Nucleic Acids Res. 32:1836–1847. 2004. View Article : Google Scholar : PubMed/NCBI
19	Zhao Z, Hao D, Wang L, Li J, Meng Y, Li P, Wang Y, Zhang C, Zhou H, Gardner K, et al: CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling. Oncogene. 38:2076–2091. 2019. View Article : Google Scholar : PubMed/NCBI
20	Dcona MM, Damle PK, Zarate-Perez F, Morris BL, Nawaz Z, Dennis MJ, Deng X, Korwar S, Singh SJ, Ellis KC, et al: Active-site tryptophan, the target of antineoplastic C-terminal binding protein inhibitors, mediates inhibitor disruption of CtBP oligomerization and transcription coregulatory activities. Mol Pharmacol. 96:99–108. 2019. View Article : Google Scholar : PubMed/NCBI
21	Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, et al: Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 40:310–315. 2008. View Article : Google Scholar : PubMed/NCBI
22	Guan C, Shi H, Wang H, Zhang J, Ni W, Chen B, Hou S, Yang X, Shen A and Ni R: CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A. J Cell Biochem. 114:1343–1354. 2013. View Article : Google Scholar : PubMed/NCBI
23	Shi H, Mao Y, Ju Q, Wu Y, Bai W, Wang P, Zhang Y and Jiang M: C-terminal binding protein-2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis. Int J Oncol. 53:167–176. 2018.PubMed/NCBI
24	Wang Y, Liu F, Mao F, Hang Q, Huang X, He S, Wang Y, Cheng C, Wang H, Xu G, et al: Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration. J Biol Chem. 288:9028–9034. 2013. View Article : Google Scholar : PubMed/NCBI
25	Shi H, Xu J, Zhao R, Wu H, Gu L and Chen Y: FGF2 regulates proliferation, migration, and invasion of ECA109 cells through PI3K/Akt signalling pathway in vitro. Cell Biol Int. 40:524–533. 2016. View Article : Google Scholar : PubMed/NCBI
26	Shah A, Melhuish TA, Fox TE, Frierson HF Jr and Wotton D: TGIF transcription factors repress acetyl CoA metabolic gene expression and promote intestinal tumor growth. Genes Dev. 33:388–402. 2019. View Article : Google Scholar : PubMed/NCBI
27	Wang Y, Shi L, Li J, Li L, Wang H and Yang H: Long-term cadmium exposure promoted breast cancer cell migration and invasion by up-regulating TGIF. Ecotoxicol Environ Saf. 175:110–117. 2019. View Article : Google Scholar : PubMed/NCBI
28	Wotton D and Taniguchi K: Functions of TGIF homeodomain proteins and their roles in normal brain development and holoprosencephaly. Am J Med Genet C Semin Med Genet. 178:128–139. 2018. View Article : Google Scholar : PubMed/NCBI
29	Nakashima H, Tsujimura K, Irie K, Ishizu M, Pan M, Kameda T and Nakashima K: Canonical TGF-β signaling negatively regulates neuronal morphogenesis through TGIF/Smad complex-mediated CRMP2 suppression. J Neurosci. 38:4791–4810. 2018. View Article : Google Scholar : PubMed/NCBI
30	Sharma A, Sinha NR, Siddiqui S and Mohan RR: Role of 5′TG3′-interacting factors (TGIFs) in Vorinostat (HDAC inhibitor)-mediated Corneal Fibrosis Inhibition. Mol Vis. 21:974–984. 2015.PubMed/NCBI
31	Du R, Shen W, Liu Y, Gao W, Zhou W, Li J, Zhao S, Chen C, Chen Y, Liu Y, et al: TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness. Signal Transduct Target Ther. 4:602019. View Article : Google Scholar : PubMed/NCBI
32	Liu ZM, Tseng HY, Tsai HW, Su FC and Huang HS: Transforming growth factor β-interacting factor-induced malignant progression of hepatocellular carcinoma cells depends on superoxide production from Nox4. Free Radic Biol Med. 84:54–64. 2015. View Article : Google Scholar : PubMed/NCBI
33	Zhang MZ, Ferrigno O, Wang Z, Ohnishi M, Prunier C, Levy L, Razzaque M, Horne WC, Romero D, Tzivion G, et al: TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesis. Cancer Cell. 27:547–560. 2015. View Article : Google Scholar : PubMed/NCBI
34	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
35	Shi H, Shi J, Zhang Y, Guan C, Zhu J, Wang F, Xu M, Ju Q, Fang S and Jiang M: Long non-coding RNA DANCR promotes cell proliferation, migration, invasion and resistance to apoptosis in esophageal cancer. J Thorac Dis. 10:2573–2582. 2018. View Article : Google Scholar : PubMed/NCBI
36	Mo Y, Wang Y, Zhang S, Xiong F, Yan Q, Jiang X, Deng X, Wang Y, Fan C, Tang L, et al: Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2. Mol Cancer. 20:1122021. View Article : Google Scholar : PubMed/NCBI
37	Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45((W1)): W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
38	Shetti D, Zhang B, Fan C, Mo C, Lee BH and Wei K: Low dose of paclitaxel combined with XAV939 attenuates metastasis, angiogenesis and growth in breast cancer by suppressing Wnt signaling. Cells. 8:82019. View Article : Google Scholar
39	Huang X, Zhou X, Hu Q, Sun B, Deng M, Qi X and Lü M: Advances in esophageal cancer: A new perspective on pathogenesis associated with long non-coding RNAs. Cancer Lett. 413:94–101. 2018. View Article : Google Scholar : PubMed/NCBI
40	Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al: The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 45(D1): D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
41	Wang Y, Shi L, Li J, Wang H and Yang H: The roles of TG-interacting factor in cadmium exposure-promoted invasion and migration of lung cancer cells. Toxicol In Vitro. 61:1046302019. View Article : Google Scholar : PubMed/NCBI
42	Zhang LN, Zhao L, Yan XL and Huang YH: Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways. J Cell Physiol. 234:20469–20484. 2019. View Article : Google Scholar : PubMed/NCBI
43	Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, Wu C, Wang C and Ye L: Wnt/β-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 6:3072021. View Article : Google Scholar : PubMed/NCBI